The levels of FAP protein (Figure 1A, left panel) and FAP enzymatic activity (Figure 1A, right panel) were substantially higher in glioblastomas than in non-tumorous pharmacoresistant epilepsy (PRE) brain tissues. The gene discussed is FAP; the disease is glioblastoma.